Your browser doesn't support javascript.
loading
[Comprehensive therapy of traditional Chinese medicine for erectile dysfunction with damp-heat stasis: A clinical observation of 103 cases].
Yao, Jun-Chao; Ju, Bao-Jun; Li, Xiao; Li, Lu-Yu; Ma, Miao-Miao; Zhang, Yong-Tao.
Afiliação
  • Yao JC; Department of Traditional Chinese Medicine, Xuzhou First People's Hospital, Xuzhou, Jiangsu 221000, China.
  • Ju BJ; Department of Andrology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China.
  • Li X; Department of Andrology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China.
  • Li LY; Department of Andrology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China.
  • Ma MM; Department of Andrology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China.
  • Zhang YT; Department of Andrology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China.
Zhonghua Nan Ke Xue ; 30(3): 233-240, 2024 Mar.
Article em Zh | MEDLINE | ID: mdl-39177390
ABSTRACT

OBJECTIVE:

To assess the clinical effect and safety of comprehensive therapy of traditional Chinese medicine (TCM) in the treatment of erectile dysfunction (ED) with damp-heat stasis.

METHODS:

We selected 108 cases of ED with damp-heat stasis meeting the inclusion criteria and treated with tadalafil (the control group, n = 54) or tadalafil + comprehensive TCM therapy (the trial group, n = 54) in the First Affiliated Hospital of Henan University of Chinese Medicine in the same period. After 8 weeks of treatment, we recorded the patients' scores on IIEF-5, TCM syndrome, erectile quality (EQS), 9-Item Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Scale 7 (GAD-7). At 16 weeks of our study, we collected the efficacy parameters, safety indicators and adverse reactions by telephone follow-up and compared the data obtained between the two groups of patients.

RESULTS:

Totally, 103 of the patients completed the study, 51 in the control and 52 in the trial group. Compared with the baseline, the IIEF-5 and EQS scores were both markedly increased after 8 weeks of treatment in the trial group (12.35±3.00 vs 18.36±2.82, P< 0.05; 39.5 ï¼»30.25-43ï¼½ vs 67.5 ï¼»54.5-76.75ï¼½, P< 0.05) and the control (11.96±2.79 vs 15.88±3.86, P< 0.05; 38.0 ï¼»29-42ï¼½ vs 56 ï¼»49-64ï¼½, P< 0.05), even more significantly in the former than in the latter (P< 0.05); the TCM syndrome and GAD-7 scores were remarkably decreased in the trial (9.5 ï¼»8-12ï¼½ vs 4.0 ï¼»2.25-5ï¼½, P< 0.05; 5 ï¼»2.25-6.75ï¼½ vs 2.5 ï¼»1-4.75ï¼½, P< 0.05) and the control group (10.0 ï¼»8-12ï¼½ vs 5.0 ï¼»3-6ï¼½, P< 0.05; 5.0 ï¼»3-6ï¼½ vs 4.0 ï¼»2-5ï¼½, P< 0.05), even more significantly in the former than in the latter (P< 0.05), so were the PHQ-9 scores (P< 0.05), but with no statistically significant difference between the two groups (P > 0.05). The IIEF-5 scores of the two groups remained significantly higher than the baseline during the follow-up (P< 0.05), even higher in the trial than in the control group (17.04±2.60 vs 14.16±3.34, P< 0.05). No obvious abnormal safety indicators or adverse events were observed during the study.

CONCLUSION:

Comprehensive TCM therapy combined with tadalafil is superior to tadalafil alone in the treatment of ED with damp-heat stasis, and has a better long-term efficacy and a higher safety.
Assuntos
Palavras-chave
Buscar no Google
Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Tadalafila / Disfunção Erétil / Medicina Tradicional Chinesa Limite: Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Nan Ke Xue Assunto da revista: MEDICINA REPRODUTIVA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Buscar no Google
Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Tadalafila / Disfunção Erétil / Medicina Tradicional Chinesa Limite: Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Nan Ke Xue Assunto da revista: MEDICINA REPRODUTIVA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China